CALABRESE, VITO
 Distribuzione geografica
Continente #
NA - Nord America 77
EU - Europa 53
AS - Asia 11
SA - Sud America 2
OC - Oceania 1
Totale 144
Nazione #
US - Stati Uniti d'America 75
IT - Italia 22
GB - Regno Unito 18
SG - Singapore 8
FI - Finlandia 6
CZ - Repubblica Ceca 4
CA - Canada 2
TW - Taiwan 2
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
DE - Germania 1
IN - India 1
LV - Lettonia 1
NL - Olanda 1
Totale 144
Città #
Ashburn 18
Boardman 17
London 17
Rome 7
Council Bluffs 6
Helsinki 6
Los Angeles 6
Singapore 5
Brno 4
Foggia 4
Redmond 3
San Severo 3
Santa Clara 3
Washington 3
Milan 2
San Francisco 2
Trieste 2
Amsterdam 1
Buenos Aires 1
Burbank 1
Canberra 1
Mumbai 1
Naples 1
Oklahoma City 1
Riga 1
Toronto 1
Totale 117
Nome #
Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study 25
Simultaneous presence of Brugada and overgrowth syndromes 22
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 22
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 17
Impact of the high-frequency cutoff of bandpass filtering on ECG quality and clinical interpretation: A comparison between 40Hz and 150Hz cutoff in a surgical preoperative adult outpatient population 15
The endogenous lusitropic and chronotropic agent, B-type natriuretic peptide, limits cardiac troponin release in cancer patients with an early impairment of myocardial relaxation induced by anthracyclines 13
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial 11
Pharmacology of cardio-oncology: chronotropic and lusitropic effects of B-type natriuretic peptide in cancer patients with early diastolic dysfunction induced by anthracycline or nonanthracycline chemotherapy 10
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 9
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 9
Totale 153
Categoria #
all - tutte 2.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 8 3 0 1 9
2022/202325 1 0 10 0 0 0 5 0 1 1 7 0
2023/202467 2 6 3 6 9 27 1 2 5 1 1 4
2024/202540 10 5 15 4 6 0 0 0 0 0 0 0
Totale 153